ABOUT ME
Eric Rush is a clinical geneticist with a focus on metabolic bone disease, dysmorphology, and cancer geneticist. His research interests include osteogenesis imperfecta, hypophosphatasia, and peroxisomal biogenesis disorders. He is also very interested in the potential in collaboration between industry and health care. Teaching is also a major focus, and Dr. Rush is currently an Associate Professor of Pediatrics at the University of Missouri-Kansas City and a Clinical Associate Professor of Medicine at the University of Kansas Medical Center.
EDUCATION
RESEARCH INTERESTS
Best Practices in Metabolic Bone Disease
Standards of care are only emerging for many rare diseases. My interest is to collaborate on development of best practices that will be beneficial to patients and practical for providers
1997 - 2001
University of Kansas
Bachelor of Science, Biology (Genetics)
Bachelor of Science, Biochemistry
Phenotyping of Syndromes with Recent Molecular Characterization
The Human Genome Project was a monumental undertaking, but really represented only the first step in the journey of discovery. Of the approximately 20,000 human genets, we only know what happens when around 5,000 of them malfunction. New syndromes are frequently described, and the etiology of known syndromes frequently discovered.
Skeletal Manifestations of Peroxisomal Disease
Peroxisomal Biogenesis Disorders include what is now known as the Zellweger Syndrome Spectrum (ZSS), which encompasses Zellweger Syndrome, Neonatal Adrenoleukodystrophy, and Infantile Refsum Disease. These are progressive disorders, and it has become clear that there is a risk of bone fragility and fractures which cannot be completely explained by loss of ambulation.
2001 - 2005
University of Kansas Medical Center
Doctor of Medicine
2009 - 2010
University of Nebraska Medical Center
Chief Resident, Pediatrics
2005 - 2009
University of Nebraska Medical Center
Resident, Internal Medicine and Pediatrics
2010 - 2012
University of Nebraska Medical Center
Fellow, Clinical Genetics